JPRN-UMIN000001919已完成2 期
Randomized phase II study comparing chemotherapy led by using the classification of primary tumor origin with empirical chemotherapy for patients with unknown primary cancer . - Randomized phase II study for patients with unknown primary cancer.
Ministry of Health, Labour and Welfare scientific research Nakagawa squad0 个研究点目标入组 120 人开始时间: 2009年4月30日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)cases with the adaptation of radical operation and the radical irradiation (2)Patient subgroups known to have favorable features are excluded. These subgroups include as follows: (a)women with adenocarcinoma involving only axillary lymph nodes (b)women with adenocarcinoma involving the peritoneal cavity (c)patients with squamous cell carcinoma involving only cervical lymph nodes (d)patients with squamous cell carcinoma involving only inguinal lymph nodes (e)patients with poorly differentiated carcinoma consistent with a germ cell tumor or neuroendcrine carcinomas (f)men with osteosclerosis-related bone metastases and elevated PSA in their plasma or tumor (3)active infection or other severe complications (such as gastrointestinal bleeding, heart disease) (4)symptomatic brain tumor (5)interstitial pneumonitis or pulmonary fibrosis (6)patients who underwent bone marrow transplantation (7)patients who underwent peripheral blood stem cell transplantation (8)severe drug allergy (9)alcohol intolerance (10) HBsAg(+) (11)pregnant or lactating women (12)men with the pregnant intention (13)uncontrollable diabetis mellitus
研究者
相似试验
进行中（未招募）
不适用
A Randomized Phase II Study of two chemotherapy regimens, Pemetrexed-Carboplatin, and Gemcitabine-Vinorelbine, in Anthracycline and Taxane Pretreated Advanced Breast Cancer Patients - NDWomen with histologic or cytologic diagnosis of advanced breast cancer, who have received one prior chemotherapy containing anthracyclines as neo adjuvant or palliative 1st-line treatment and one prior chemotherapy containing taxanes as neo adjuvant or palliative 1st-line treatment.MedDRA version: 8.1Level: LLTClassification code 10055113Term: Breast cancer metastaticEUCTR2006-000441-19-ITELI LILLY160
进行中（未招募）
不适用
A randomised Phase II study of two chemotherapy regimens, Pemetrexed-Carboplatin, and Gemcitabine-vinorelbine, in Anthracycline and Taxane pretreated Advanced Breast cancer patients.advanced breast cancerMedDRA version: 8.0Level: LLTClassification code 10006285EUCTR2006-000441-19-DEEli lilly and Company Limited144
进行中（未招募）
不适用
Randomized fase II study using chemiotherapy with metformine in patients affected by pancreas metastatic cancer. - NDpancreas metastatic tumorMedDRA version: 9.1Level: HLTClassification code 10033632EUCTR2010-020979-23-ITFONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
进行中（未招募）
不适用
Randomised phase II trial on primary chemotherapy with high-dose Methotrexate and high-dose Cytarabine with or without Thiotepa, and with or without Rituximab, followed by brain irradiation vs high-dose chemotherapy supported by autologous stem cells transplantation for immunocompetent patients with newly diagnosed Primary CNS Lymphoma. - IELSG 32EUCTR2009-012432-32-GBniversity Hospital Southampton NHS Foundation Trust126
已完成
2 期
Randomized Phase II Trial On Primary Chemotherapy With High-Dose Methotrexate And High-Dose Cytarabine With Or Without Thiotepa, And With Or Without Rituximab, Followed By Brain Irradiation Vs. High-Dose Chemotherapy Supported By Autologous Stem Cells Transplantation For Immunocompetent Patients With Newly Diagnosed Primary CNS LymphomaCentral Nervous System LymphomaDRKS00003763niversitätsklinikum Freiburg, Abt. Med 1, Hämatologie/ Onkologie227